Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9379 |
High Similarity |
NPD7074 |
Phase 3 |
0.9317 |
High Similarity |
NPD7054 |
Approved |
0.9259 |
High Similarity |
NPD7472 |
Approved |
0.9136 |
High Similarity |
NPD3818 |
Discontinued |
0.9091 |
High Similarity |
NPD7808 |
Phase 3 |
0.903 |
High Similarity |
NPD7251 |
Discontinued |
0.8994 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.897 |
High Similarity |
NPD6797 |
Phase 2 |
0.8862 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8812 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD6166 |
Phase 2 |
0.8742 |
High Similarity |
NPD1934 |
Approved |
0.8735 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8428 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8363 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8363 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8344 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8313 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8303 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8294 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8293 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8068 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD37 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8036 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8024 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8024 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7952 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7944 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7937 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7885 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7821 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7798 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7758 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7735 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7696 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7592 |
Intermediate Similarity |
NPD7584 |
Approved |
0.758 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7553 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7543 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7526 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7526 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9494 |
Approved |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD943 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7461 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7457 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7435 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7414 |
Intermediate Similarity |
NPD919 |
Approved |
0.7409 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7354 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7321 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7273 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7228 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7216 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7211 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7204 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7198 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD920 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD6273 |
Approved |
0.707 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7011 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6988 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6982 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD8166 |
Discontinued |
0.697 |
Remote Similarity |
NPD6651 |
Approved |
0.6968 |
Remote Similarity |
NPD9545 |
Approved |
0.6964 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6957
|
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |